The Covid vaccine, developed by Oxford University and leading pharmaceutical company AstraZeneca, is expected to be ready for use in India by December, said Adar Poonawala, head of the Serum Institute. It will be ready for use in December if the government takes immediate action to get the wax approved. Otherwise, it will extend to January, he said.
The Pune-based Serum Institute has been contracted to manufacture the Covid vaccine in India, which is being developed by Oxford University and leading pharmaceutical company AstraZeneca. The company aims to distribute the vaccine widely in the country in the second or third quarter of next year. According to Adar Poonawala, the company plans to prepare a 10 crore dose for the first phase.
The Covid vaccine may have to wait until January to be ready for use if the vaccine is not immediately licensed or the vaccine trial continues. Poonawala said the trial of the vaccine in the UK also needs to be completed. The third phase of the vaccine test is underway. Efforts are being made at the government level to get immediate approval for this to be completed successfully. It is estimated that the Covid situation in the country at the end of this year will also affect this. The vaccine will be given first according to the priority order prepared by the Central Government.